Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

INT-SCART-001: A Phase I Study Evaluating the Safety of Stereotactic Central Ablative Radiation Therapy (SCART) for Bulky Metastatic or Recurrent Cancer.

NCT04881981 is registered in ClinicalTrials.gov with Baptist Health, Louisville as lead sponsor.

NCT NCT04881981
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04881981 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
INT-SCART-001: A Phase I Study Evaluating the Safety of Stereotactic Central Ablative Radiation Therapy (SCART) for Bulky Metastatic or Recurrent Cancer.
Lead sponsor
Baptist Health, Louisville
Phase
Phase 1
Overall status
Unknown status
Start date
June 5, 2021
Completion date
May 5, 2022
Enrollment
12 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

malignant neoplasms